Riskpilot← Back to searchSign inGet full accessCherif and Cherif AB
ABActiveOrg 5569860884Jarlers Väg 14Retail sale of pharmaceutical products · NACE 4773Est. 20140 employees
Revenue 2025
SEK 0
EBITDA margin
—
-291% vs 2024
Equity ratio
95.8%
Financial strength
Net profit 2025
SEK -12K
-338% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -12K | -291% |
| Net profit | SEK -12K | -338% |
| Total assets | SEK 139K | -10% |
| Equity | SEK 133K | -8% |
| Employees | 0 | — |
Legal name
Cherif and Cherif AB
Org number
5569860884
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
13 oktober 2014
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är direkt eller indirekt tillhandahållande av varor och tjänster inom läkemedelsområdet, handel med värdepapper, förvaltning fast egendom och därmed för- enlig verksamhet.
Address
Jarlers Väg 14
Email
aseel.cherif@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 23 | 47 | 10 | 18 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −14 | 37 | −2 | 6 | −12 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −14 | 37 | −2 | 6 | −12 |
| Net financials | — | — | 0 | −0 | 0 |
| Profit before tax | −14 | 37 | −2 | 6 | −12 |
| Tax | −0 | −5 | — | −1 | — |
| Net profit | −14 | 32 | −2 | 5 | −12 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 114 | 162 | 150 | 155 | 139 |
| Equity | 110 | 142 | 140 | 146 | 133 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 4 | 20 | 10 | 9 | 6 |
| Total debt | 4 | 20 | 10 | 9 | 6 |
EBITDA margin
-1212500.0%
This company
15.8%
Market median
-7674151% vs market
20212025
Equity ratio
95.8%
This company
38.2%
Market median
+151% vs market
20212025
Return on equity
-9.0%
This company
18.4%
Market median
-149% vs market
20212025
Net profit margin
-1206100.0%
This company
8.1%
Market median
-14890223% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CC Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cherif and Cherif AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cherif Cherif | Deputy Chief Executive Officer | 0 companies |
| Honar Cherif | Deputy Board Member | 0 companies |
| Evin Cherif | Chairman | 0 companies |
| Aseel Abed Al Mahmad Cherif | Board of Directors | 0 companies |